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Aim of the study: To evaluate if perennial non-infectious rhinitis is associated with sleep
disturbances in asthma.
Materials and methods: This is a questionnaire based study in a random population sample
from Denmark, Estonia, Iceland, Norway and Sweden aged 30–54 yr. A total of 1127
individuals reporting asthma from an original random population sample of 16,191 were
analysed regarding their quality of sleep in relation to perennial non-infectious rhinitis.
Perennial non-infectious rhinitis was defined as having nasal symptoms such as nasal
blockage and secretion in the absence of common cold, always. Asthma was defined as
both ever having had asthma and having physician diagnosed asthma. Odds ratios (OR) for
difficulties inducing sleep, difficulties maintaining sleep, early morning awakenings and
daytime sleepiness were calculated in a multiple logistic regression controlling for other
risk factors for sleep disturbances such as snoring, wheeze, obesity and smoking.
Results: The response rate was 74%. A total of 189 (17%) of the subjects with asthma
reported perennial non-infectious rhinitis. Perennial non-infectious rhinitis was associated
with an increased OR for difficulties maintaining sleep (1.6 (95% confidence interval (CI)
1.1–2.3)), early morning awakenings (1.5 (95% CI 1.1–2.2)) and daytime sleepinessElsevier Ltd. All rights reserved.
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J. Hellgren et al.1016(1.8 (95% CI 1.2–2.9)). The result show that perennial non-infectious rhinitis is an
independant risk factor for sleep disturbances in asthma.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Asthma has previously been associated with sleep distur-
bances and daytime symptoms related to poor sleep.
Episodes of nocturnal awakenings or early morning awaken-
ings, at least once per week, difficulty in maintaining sleep
and daytime sleepiness have been found in 74% of patients
with asthma.1 In another study of 98 patients with asthma
and 226 healthy controls, asthma was significantly asso-
ciated with early morning awakenings, difficulty in main-
taining sleep and daytime sleepiness.2
The mechanism behind impaired sleep in asthma remains
unclear but several hypothesis have been suggested.
Nocturnal asthma can induce increased airway resistance
based on airway inflammation and there are circadian
variations in bronchial hyper responsiveness over night.3
Asthma has also been associated with increased snoring and
apnoeas which can cause disrupted sleep and daytime
sleepiness.4 In a large European population based study,
‘‘The European Community Respiratory Health Survey’’
(ECRHS 1), allergic rhinitis was found to be an independent
risk factor for daytime sleepiness, difficulty inducing sleep,
daytime tiredness, but not for early morning awakenings.5
Studies on non-asthmatic subjects have shown that
allergic rhinitis is associated with sleep disturbances such
as an increased number of ‘microarousals’ (short awaken-
ings) and more daytime sleepiness compared to controls.6,7
Nasal obstruction is believed to be the most important
symptom behind poor sleep in rhinitis. Several experimental
studies in healthy individuals have shown that sleep
disturbances are induced when the nose is blocked with
adhesive tape or petroleum jelly during sleep.8–10 It has also
been shown that nasal steroids have an effect on relieving
nasal obstruction and that treatment with nasal steroids in
allergic rhinitis patients has a significant positive effect on
subjective sleep compared to placebo.7,11–14
Allergic rhinitis has been reported in 78–85% of patients
with asthma but other forms of inflammatory nasal disease
such as non-allergic rhinitis and nasal polyps are also
common in asthma.15,16 To evaluate the impact of inflam-
matory nasal disease on sleep in asthma we have assessed
perennial non-infectious rhinitis which is a wider definition
of rhinitis, including allergic rhinitis, non-allergic rhinitis
and nasal polyps based on the presence of specific nasal
symptoms.17 The aim of this study was to evaluate if
perennial non-infectious rhinitis is associated with sleep
disturbances in asthma.Material and methods
The population of this study were subjects (n ¼ 21,802) born
between 1945 and 1973 who participated in stage 1 of the
European Community Respiratory Health Survey (ECRHS I) in
1989–92 from Reykjavik in Iceland; Bergen in Norway;Umea˚, Uppsala, and Go¨teborg in Sweden; Aarhus in Den-
mark; and Tartu in Estonia. At follow-up, in 1999–2001, the
eligible subjects were mailed a questionnaire, of which
16,191 (74%) answered. The subjects who reported asthma
according to our definition below, n ¼ 1127, were included
in the study after excluding 44 subjects who had left
incomplete answers regarding having asthma or not.
The assessed parameters in the questionnaire were
defined as follows.
Asthma was defined as answering positive to both: ‘‘Do
you have, or have you ever had asthma?’’ and ‘‘Have you
ever had asthma diagnosed by a doctor?’’ (Physician
diagnosed asthma).18
Perennial non-infectious rhinitis was defined as the
positive answer to ‘‘Have you ever had nasal problems such
as nasal obstruction, secretion, itching and/or attacks of
sneezing when you did not have a cold or the flu?’’ followed
by the answer ‘‘always’’ to the question ‘‘What time of the
year are your nasal symptoms worst?’’.19,20 The alternative
answers on the second question were: spring, summer,
autumn, winter, always, do not know.
Hay-fever was defined as the positive answer to the
question: ‘‘Do you have any nasal allergies including hay-
fever’’.15
Perennial Allergic rhinitis was defined as the positive
answer to ‘‘Do you have any nasal allergies including hay-
fever’’, followed by the answer ‘‘always’’ to the question
‘‘What time of the year are your nasal symptoms worst?’’
The alternative answers on the second question were:
spring, summer, autumn, winter, always, do not know.
Sleep disturbances were assessed by multiple choice
questions where the subjects were asked to estimate the
frequency of different symptoms during the last months on a
five point scale: 1 ¼ never; 2 ¼ less than once a week;
3 ¼ 1–2 nights a week; 4 ¼ 3–5 nights a week; 5 ¼ almost
nightly/daily. The different symptoms were defined positive
if they occurred 3–5 times/week or more.Difficulties inducing sleep: Difficulties falling asleep
at nightDifficulties maintaining
sleep:Wake up several times
during the nightEarly morning awakenings: Wake up early and cannot
go back to sleepDaytime sleepiness: Feel sleepy during the
day21Snoring was defined as the positive answer to the
question: ‘‘Do you snore?’’
Smoking was assessed with the question: ‘‘Do you
smoke?’’
Ex-smoking was assessed with the question ‘‘Are you an
ex-smoker?’’
Wheeze was defined as the positive answer to the
question: ‘‘Have you had wheeze sometime during the last
12 months?’’
ARTICLE IN PRESS
Perennial non-infectious rhinitis 1017Obesity was defined as a BMI 430 kg/m2 calculated
according to the BMI formula body weight (kg)/(length
(metres))2.
The study was approved by the local ethics committee of
the respective participating centres.Statistics
The statistical analyses were made using the SAS statistical
software pack. Comparisons regarding categorical variables
were made with Chi-square test. The risks for daytime
sleepiness, etc among subjects with perennial allergic
rhinitis and perennial non-infectious rhinitis were calculated
as ORs using a multiple logistic regression model (PROC
LOGIST). As confounders the models included age, sex,
obesity (BMI430 kg/m2), smoking, ex-smoking, snoring and
hay-fever.Table 1 Baseline data for subjects with physician
diagnosed asthma stratified by Perennial and Non-
Infectious Rhinitis (PNIR). BMI ¼ body mass index,
STD ¼ standard deviation. % of subjects within brackets.
PNIR (+) PNIR (–) P-value
(n ¼ 189) (n ¼ 938)
Age at follow up 4077.4 3977.2 0.1
Females % (61) (57) 0.3
Smoker % (34) (28) 0.09
Hay fever % (61) (55) 0.1
Wheeze % (76) (64) 0.002
BMI kg/m2 2574.4 2574.5 0.6
Prevalence 
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Figure 1 Prevalence of sleep disorders (%) in the study populatio
infections rhinitis (PNIR+ vs. PNIR-).Results
The response rate in the original sample of 16.191 subjects
was 74%. Of the 1127 subjects who reported asthma, 189
(17%) reported perennial non-infectious rhinitis. Baseline
data for the study population are presented in Table 1.
There was significantly more wheeze in the perennial non-
infectious rhinitis group and there was a predominance of
women, hay-fever and smokers in this group compared to
the subjects with asthma reporting no perennial non-
infectious rhinitis, but the differences were not significant.
The prevalence figures of sleep disturbances stratified by
perennial non-infectious rhinitis are shown in Fig. 1. There
were significantly more difficulties maintaining sleep, early
morning awakenings and daytime sleepiness in the perennial
non-infectious rhinitis group.
In the multiple logistic regression there was an indepen-
dent association between perennial non-infectious rhinitis
and difficulties maintaining sleep, early morning awakenings
and daytime sleepiness (Table 2).
Perennial allergic rhinitis was reported by 116 (10%) of
the subjects with asthma. In the logistic regression model
including sex, age, obesity, wheeze, snoring and smoking,
perennial allergic rhinitis was associated with difficulties
maintaining sleep, odds ratio (OR) 1.5 (1.0–2.4) but not with
difficulties inducing sleep OR 1.2 (0.6–2.1), early morning
awakenings OR 1.7 (0.9–2.9) or daytime sleepiness OR 1.3
(0.9–2.1).
Difficulties maintaining sleep and early morning awaken-
ings were almost exclusively related to perennial non-
infectious rhinitis. Daytime sleepiness, however, was related
to several risk factors such as snoring OR1.7 (1.2–2.4),
smoking OR 1.3 (1.0–1.8), female gender OR 1.6 (1.2–2.2),
wheeze OR 1.4 (1.1–1.9) and perennial non-infectiousof sleep disturbances
p Early morning awakenings Daytime sleepiness
PNIR +
PNIR -
p=0.001
p=0.003
n and p-values for the difference, stratified by perennial non-
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Table 2 Multiple regression analyses of sleep disturbances in the asthma population, odds ratio (95% confidence intervals)
controlling for age, gender, obesity (BMI 430 kg/m2), snoring, smoking.
DIS DMS EMA DS
PNIR 1.2 (0.8–2.0) 1.5 (1.1–2.2) 1.8 (1.2–2.9) 1.6 (1.1–2.3)
Snoring 1.0 (0.6–1.6) 1.3 (0.9–1.8) 1.3 (0.8–1.9) 1.7 (1.2–2.4)
Obesity 1.2 (0.7–2.1) 1.2 (0.8–1.8) 1.5 (0.9–2.5) 1.2 (0.8–1.8)
Wheeze 1.7 (1.1–2.6) 1.1 (0.8–1.6) 1.3 (0.9–2.0) 1.4 (1.1–1.9)
Smoking 2.6 (1.7–3.8) 0.8 (0.6–1.1) 1.3 (0.8–1.9) 1.3 (1.0–1.8)
Female sex 1.3 (0.9–1.9) 1.7 (1.2–2.3) 1.1 (0.7–1.6) 1.6 (1.2–2.2)
DMS ¼ difficulties maintaining sleep, EMA ¼ early morning awakenings, DS ¼ daytime sleepiness, PNIR ¼ Perennial non-infectious
rhinitis.
J. Hellgren et al.1018rhinitis OR 1.6 (1.1–2.3), reflecting that even though
excessive day-time sleepiness is a common symptom in
relation to sleep disordered breathing, it is less specific.
Difficulty inducing sleep was not related to perennial rhinitis
at all in this study, but to smoking OR 2.6 (1.7–3.8) and
wheeze OR 1.7 (1.1–2.6).
Both obesity and snoring are risk factors associated with
sleep disordered breathing and obstructive sleep apnoea
syndrome that can cause sleep fragmentation and daytime
symptoms.22,23 When controlling for obesity (in this study
defined as body mass index 430 kg/m2) and snoring in the
logistic regression model, perennial non-infectious rhinitis,
however, remained an independent risk factor for sleep
disturbances in the asthma population.Discussion
In this population sample of 1127 subjects with physician
diagnosed asthma, perennial non-infectious rhinitis was an
independent risk factor for difficulties maintaining sleep,
early morning awakenings and daytime sleepiness. The
results show that perennial non-infectious rhinitis contri-
bute to sleep fragmentation and daytime sleepiness in
asthma. Objective data from polysomnography studies of
seasonal allergic rhinitis show that rhinitis alone can cause
sleep fragmentation and short awakenings and the agree-
ment with the self-reported data from this study, suggest
that rhinitis has a similar effect on sleep in asthma.6 In the
absence of a clinical sleep evaluation, such as a polysomno-
graphy, it is not possible, however, to analyse by which
mechanism perennial non-infectious rhinitis affects sleep in
asthma.
This study is the first to our knowledge that has evaluated
persistent nasal symptoms in relation to sleep in a
questionnaire study of asthma. The study confirms the
finding from the ECHRS 1 survey that rhinitis is an
independent risk factor for daytime sleepiness in asthma.
In addition this study showed an association with difficulties
maintaining sleep and early morning awakenings, not found
in the ECHRS 1, but in accordance with the previous studies
of allergic rhinitis. There was, however, no association
between rhinitis and difficulties inducing sleep as shown in
the ECHRS 1. The main reason for these discrepancies could
be that the definition of allergic rhinitis, used in the ECHRS 1
(reporting having nasal allergy including hay fever) isunspecific in terms of presence and duration of nasal
symptoms. Nasal allergy and hay-fever is also strongly
associated with non-nasal symptoms such as conjunctivitis
and general fatigue.
A validation of questions asking for specific nasal
symptoms used in a postal questionnaire, such as the non-
infectious rhinitis question, has shown a specificity of 91%
and a sensitivity of 96% compared to personal in-depth
interviews of rhinitis.24 The reason we have used a wider
definition of rhinitis (perennial non-infectious rhinitis) was
to avoid the risk of excluding subjects with nasal symptoms
who did not relate their symptoms to an allergic disease.
Nasal obstruction, secretion and itching are common
symptoms in asthma and can be caused by allergic rhinitis,
non-allergic rhinitis and nasal polyps and in the absence of a
nasal examination it is difficult to tell the difference based
on nasal symptoms.17,25 For instance, allergic rhinitis is
often perceived as nasal symptoms that arise in relation to
exposure to allergens, such as pollens, dust and fur animals,
where as non-allergic rhinitis or nasal polyposis often lack a
clear cut relationship to exposures. Structural problems in
the nose such as septal deviations or turbinate hypertrophy
may also cause nasal obstruction, but in a Swedish normal
population, structural problems accounted for symptoms of
nasal obstruction in only 2–3%.26
To assure that we were evaluating ongoing nasal
symptoms, only those who reported symptoms being worst
‘‘always’’, were defined as having perennial disease. This
would have increased the specificity of the rhinitis diagnosis
at the expense of the sensitivity.
In previous questionnaire studies, based on general
questions for nasal allergy such as self reported allergic
rhinitis and hay fever, or confirming having nasal symptoms
after contact with seasonal or perennial allergens, 78–86%
of subjects with asthma report allergic rhinitis.15,16 The
results from this study, however, showed that when asking
for specific nasal symptoms ‘‘always’’, the prevalence
dropped to 17%, indicating that even though the prevalence
of rhinitis in asthma is high, most patients do not have
symptoms all the time. Because allergic rhinitis is the
predominant form of rhinitis in asthma we analysed
perennial allergic rhinitis separately. Perennial allergic
rhinitis, showed a weaker relationship with impaired sleep.
This could again reflect a lower sensitivity for the allergy
question to pick up nasal inflammatory disease or the fact
that there were a lower number of subjects reporting
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rhinitis. Significantly more wheeze was reported in the
perennial non-infectious rhinitis group, indicating a worse
asthma. Since asthma is characterised by a generalised air
way inflammation, more wheeze could indicate more nasal
inflammation. Several clinical studies have shown a close
relationship between the activity of the inflammatory
reaction in asthma between the upper and lower air-
ways.27,28 The fact that there was a stronger relationship
between perennial non-infectious rhinitis and sleep dis-
orders in asthma compared to perennial allergic rhinitis
suggest that the assessment of nasal disease in asthma
should include all rhinitis and not only allergic rhinitis.
The definition of asthma used in this study, ‘‘Physician
diagnosed asthma’’, is validated with a specificity of 0.998
and a sensitivity of 0.36 for the asthma diagnosis.29 To
further increase specificity, only subjects reporting both
‘‘ever having asthma’’ and having ‘‘physician diagnosed
asthma’’ were defined as having asthma, but because of the
low sensitivity we will probably have missed some milder
cases of asthma. The use of self-reported asthma in this
study may have resulted in misclassification in relation to
chronic obstructive pulmonary disease (COPD). This mis-
classification is, however, age dependent, because COPD
mainly occurs after 50 yr of age and in this study the oldest
subjects were 54 yr, which to some extent minimises the risk
for misclassification in relation to COPD.
In conclusion, we have found that perennial non-
infectious rhinitis is an independent risk factor for sleep
disturbances in asthma.Acknowledgements
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